Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-003952
Filing Date
2025-01-16
Accepted
2025-01-16 08:04:21
Documents
1
Period of Report
2025-01-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm252892-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm252892-2_4seq1.xml 4 4123
  Complete submission text file 0001104659-25-003952.txt   5577
Mailing Address C/O OCERA THERAPEUTICS, INC. 525 UNIVERSITY AVENUE, SUITE 610 PALO ALTO CA 94301
Business Address
Patni Rajiv (Reporting) CIK: 0001616200 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38410 | Film No.: 25534341

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)